SEC 13F Intelligence

Consonance Capital Management LP / SLN

Consonance Capital Management LP’s Silence Therapeutics PLC Position

Does Consonance Capital Management LP own Silence Therapeutics PLC (SLN)? Not currently — the last reported position was 634.3K shares worth $8M in Q2 2022; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$8M
Q2 2022
Shares
634.3K
% of Portfolio
+31.70%
Quarters Held
6
position exited

Position History SLN

Reported value by quarter
Q1 ’21: $5MQ1 ’21Q2 ’21: $6MQ2 ’21Q3 ’21: $4MQ3 ’21Q4 ’21: $18MQ4 ’21Q1 ’22: $12MQ1 ’22Q2 ’22: $8MQ2 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2022634.3K$8M+31.70%
Q1 2022654.1K$12M+21.08%
Q4 2021758.3K$18M+11.82%
Q3 2021178.8K$4M+2.04%
Q2 2021222.2K$6M+0.70%
Q1 2021222.2K$5M+0.54%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of SLN.